Stock Market & Financial Investment News

News Breaks January 8, 2013 06:59 EDT ATR AptarGroup upgraded to Outperform from Neutral at RW Baird Baird upgraded AptarGroup based on improving fundamentals, recent underperformance, cost savings initiatives, and increasing pharmaceutical sales. Price target raised to $58 from $53. News For ATR From The Last 14 Days Check below for free stories on ATR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for ATR Sign up for a free trial to see the rest of the stories you've been missing.